You are here

China

FDA's Hahn: No sign China has affected U.S. drug supply during coronavirus pandemic

FDA's Hahn: No sign China has affected U.S. drug supply during coronavirus pandemic

Fierce Pharma

Flag link:

Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report

Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report

Fierce Pharma

drug manufacturing

Flag link:

Hydroxychloroquine Is Ineffective In Treatment Of Patients Hospitalized With Covid-19, According To Small Controlled Trial From Shanghai

Hydroxychloroquine Is Ineffective In Treatment Of Patients Hospitalized With Covid-19, According To Small Controlled Trial From Shanghai

Forbes

clinical trials

hydroxychloroquine

Flag link:

Coronavirus: Woman accused of hiding COVID-19 symptoms while flying to China is former Biogen employee

Coronavirus: Woman accused of hiding COVID-19 symptoms while flying to China is former Biogen employee

Mass Live

Flag link:

Japanese Flu Drug ‘Effective’ Against Coronavirus In Clinical Trials, Chinese Officials Say

Japanese Flu Drug ‘Effective’ Against Coronavirus In Clinical Trials, Chinese Officials Say

Forbes

Fujifilm Toyama

clinical trials

Flag link:

Sanofi joins parade of drugmakers pledging no COVID-19 shortages

Sanofi joins parade of drugmakers pledging no COVID-19 shortages

Fierce Pharma

Flag link:

With weeks to go to COVID-19 vaccine trial, BioNTech lands $135M deal and advances Pfizer talks

With weeks to go to COVID-19 vaccine trial, BioNTech lands $135M deal and advances Pfizer talks

Fierce Biotech

Flag link:

How much does U.S. rely on China for drugs? FDA simply doesn't know

How much does U.S. rely on China for drugs? FDA simply doesn't know

Fierce Pharma

Flag link:

Coronavirus Spurs U.S. Efforts to End China’s Chokehold on Drugs

Coronavirus Spurs U.S. Efforts to End China’s Chokehold on Drugs

NY Times, NY

Flag link:

J&J's favorite CAR-T developer, currently owned by a Chinese CRO, is laying the groundwork for US IPO

J&J's favorite CAR-T developer, currently owned by a Chinese CRO, is laying the groundwork for US IPO

Endpoints

Flag link:

New coronavirus maps offer insights for detection and treatment

New coronavirus maps offer insights for detection and treatment

Fierce Biotech

Flag link:

China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines

China turns Roche arthritis drug Actemra against COVID-19 in new treatment guidelines

Fierce Pharma

Flag link:

Coronavirus Hits Big Medtech Where It Hurts Most – Revenue

Coronavirus Hits Big Medtech Where It Hurts Most – Revenue

Medical Devices and Diagnostics Industry

Flag link:

FDA Monitoring 20 Drugs at Risk of Shortage due to Coronavirus

FDA Monitoring 20 Drugs at Risk of Shortage due to Coronavirus

RAPS.org

Flag link:

Harvard joins coronavirus fight with $115M and a high-profile Chinese partner

Harvard joins coronavirus fight with $115M and a high-profile Chinese partner

Endpoints

Guangzhou Institute

Flag link:

Gilead Antiviral Drug Shows the Most Potential for COVID-19, Says WHO Official

Gilead Antiviral Drug Shows the Most Potential for COVID-19, Says WHO Official

Motley Fool

Gilead Sciences

Flag link:

Sanofi to start pharmaceutical ingredients company, which it says may avert future shortages

Sanofi to start pharmaceutical ingredients company, which it says may avert future shortages

Stat

drug manufacturing

Flag link:

A Chinese biotech partners with GSK to boost its coronavirus vaccine development

A Chinese biotech partners with GSK to boost its coronavirus vaccine development

Stat

Clover BioPharmaceuticals

Flag link:

Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?

Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?

Pharmaforum

Gilead Sciences

Flag link:

Everest hires ex-Lilly leader to oversee push for Chinese market

Everest hires ex-Lilly leader to oversee push for Chinese market

Fierce Biotech

Everest Medicines

Flag link:

Pages